SolutionsHello.
Please read my post Febuary 9, 2018, Re:Hello Everyone.
Even I am shocked at how close I nailed it when the shares were at $.16.
A lot of things turned out to be true.
I specifically said that they should divest themselves of the Lithium properties, put Glencore on Care&Maintanance and concentrate on Tentanine as the widths and grades were great.
Also to get financing back then at higher prices. Clean house and let shareholder know. Melrose as the head of technical matter and a director should have been let go immediately after January 4th.
That is all in the past and here is what I think going forward.
I believe that the management of this company are dysfunctional and with not enough finances currently and might possibly have trouble obtaining finances.
I believe that the best scenario would be a buyout with these low prices, hopefully buy a mid-tier current producer hungry and fully committed to getting this project moving.
The fact that Rob Lowen seems to be involved may possibly start the ball rolling.
Patients is the key here, if they get financing and dilution at these prices, this is dead money for a long time.
If June rolls around and phase 2 drilling has not happened, or even started, it may be a oppurtunity to get in just before a takeover and make some good money.
Please read that Feb 9 post, I did have solutions.
BTW, if you reread my previous post, you will see that I think that they currently have about $400,000 cash at best. Need some transparency so we know what is going on.